+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Valproate"

From
From
Dravet Syndrome Market - Global Forecast 2025-2030 - Product Thumbnail Image

Dravet Syndrome Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 194 Pages
  • Global
From
From
From
Epilepsy Drug Market - Global Forecast 2025-2030 - Product Thumbnail Image

Epilepsy Drug Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 187 Pages
  • Global
From
From
Lennox Gastaut Syndrome Global Market Report 2025 - Product Thumbnail Image

Lennox Gastaut Syndrome Global Market Report 2025

  • Report
  • July 2025
  • 175 Pages
  • Global
From
Migraine Drugs Market Report 2025 - Product Thumbnail Image

Migraine Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Lennox-Gastaut Syndrome Drug Global Market Report 2025 - Product Thumbnail Image

Lennox-Gastaut Syndrome Drug Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Bipolar Disorder Drugs and Treatment Market Report 2025 - Product Thumbnail Image

Bipolar Disorder Drugs and Treatment Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Antiepileptic Drugs Market Report 2025 - Product Thumbnail Image

Antiepileptic Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Divalproex Sodium Global Market Report 2025 - Product Thumbnail Image

Divalproex Sodium Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
From
Dravet Syndrome - Global Strategic Business Report - Product Thumbnail Image

Dravet Syndrome - Global Strategic Business Report

  • Report
  • September 2025
  • 485 Pages
  • Global
From
Epilepsy Treatment - Global Strategic Business Report - Product Thumbnail Image

Epilepsy Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 483 Pages
  • Global
From
Pediatric Epilepsy Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Pediatric Epilepsy Therapeutics - Global Strategic Business Report

  • Report
  • September 2025
  • 184 Pages
  • Global
From
Bipolar Disorder Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Bipolar Disorder Therapeutics - Global Strategic Business Report

  • Report
  • September 2025
  • 380 Pages
  • Global
From
Dravet Syndrome- Pipeline Insight, 2025 - Product Thumbnail Image

Dravet Syndrome- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Refractory Status Epilepticus - Pipeline Insight, 2025 - Product Thumbnail Image

Refractory Status Epilepticus - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

Valproate is a drug used to treat a variety of neurological disorders, including epilepsy, bipolar disorder, and migraine headaches. It is a type of anticonvulsant, meaning it works to reduce the frequency and severity of seizures. Valproate is also used to treat mania and depression, as well as to prevent migraine headaches. Valproate is available in both oral and intravenous forms, and is often prescribed in combination with other medications. Valproate is a widely used drug in the Central Nervous System (CNS) drug market. It is used to treat a variety of neurological disorders, including epilepsy, bipolar disorder, and migraine headaches. Valproate is also used to treat mania and depression, as well as to prevent migraine headaches. Valproate is available in both oral and intravenous forms, and is often prescribed in combination with other medications. Some companies in the Valproate market include AbbVie, GlaxoSmithKline, Johnson & Johnson, Pfizer, and Sanofi. Show Less Read more